GlassScriptPhysician profile
Andrew H Krinsky
NPI 1609979079
$1,689.81
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $264 · 2021: $471 · 2022: $309 · 2023: $226 · 2024: $45.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $172 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $171.51 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $523.30 | 2019-2023 | |
| Astellas Pharma US INC | $246.07 | 2019-2024 | Veozah |
| Exeltis, USA INC. | $147.50 | 2019-2024 | Slynd |
| Evofem Biosciences, INC. | $113.96 | 2021-2022 | |
| Allergan, INC. | $94.90 | 2019-2020 | |
| Amgen INC. | $94.29 | 2019-2022 | |
| Therapeuticsmd, INC. | $92.34 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $64.16 | 2021-2022 | |
| Hologic Sales and Service, LLC | $56.52 | 2022-2023 | Thinprep 2000 Processor, Aptima |
| Amag Pharmaceuticals, INC. | $55.86 | 2019-2020 | |
| Millicent US INC | $37.16 | 2020 | |
| Lupin INC. | $36.46 | 2019-2021 | |
| Pfizer INC. | $29.41 | 2023 | |
| Avion Pharmaceuticals | $29.09 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $26.64 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $24.15 | 2019 | |
| Ascend Therapeutics US, LLC | $18.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Krinsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.